EP 2481745 A1 20120801 - Redox mediators
Title (en)
Redox mediators
Title (de)
Redox-Mediatoren
Title (fr)
Médiateurs redox
Publication
Application
Priority
- EP 08762388 A 20080617
- GB 0711849 A 20070619
Abstract (en)
The present invention relates to ruthenium and osmium complexes of Formula I per se , where A is isoquinoline, guanine or adenine, and the use of ruthenium and osmium complexes as redox mediators in electrochemical biosensors. [M(A) w (B) x (C) y ] m (X z ) n Formula I
IPC 8 full level
C07F 15/00 (2006.01); C12Q 1/00 (2006.01); G01N 27/00 (2006.01)
CPC (source: EP US)
C07F 15/0026 (2013.01 - EP US); C07F 15/0053 (2013.01 - EP US); C12Q 1/004 (2013.01 - EP US)
Citation (applicant)
- WO 03097860 A1 20031127 - OXFORD BIOSENSORS LTD [GB], et al
- SCHNEIDER ET AL., INORG. CHEM., vol. 32, 1993, pages 4925
- CHE, C. M.; KWONG, S. S.; POON C. K., INORG. CHEM., vol. 24, 1985, pages 1601 - 1602
Citation (search report)
- [IP] WO 2007072018 A2 20070628 - OXFORD BIOSENSORS LTD [GB], et al
- [A] WO 0136430 A1 20010525 - THERASENSE INC [US]
- [A] GOSSENS, CHRISTIAN ET AL: "Rational design of organo-ruthenium anticancer compounds", CHIMIA , 59(3), 81-84 CODEN: CHIMAD; ISSN: 0009-4293, 2005, XP008152725
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2008155531 A1 20081224; CA 2689157 A1 20081224; CN 101801985 A 20100811; EP 2155766 A1 20100224; EP 2481745 A1 20120801; GB 0711849 D0 20070725; JP 2010531976 A 20100930; US 2011262950 A1 20111027; US 8618293 B2 20131231
DOCDB simple family (application)
GB 2008002064 W 20080617; CA 2689157 A 20080617; CN 200880020910 A 20080617; EP 08762388 A 20080617; EP 12165921 A 20080617; GB 0711849 A 20070619; JP 2010512760 A 20080617; US 66382108 A 20080617